Clinical Trial Update: Myocardial Protection and Anesthetic Agents [Phase 4]

View source ↗

Summary

This document notes the completion of a Phase 4 clinical trial studying myocardial protection and anesthetic agents in myocardial ischemia-reperfusion injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia-reperfusion Injury

Snippet

Sponsor: Cukurova University | Conditions: Myocardial Ischemic Reperfusion Injury | Phase 4 | Status: COMPLETED